Literature DB >> 11557174

The 5HT1Dbeta receptor gene in bipolar disorder: a family-based association study.

E Mundo1, G Zai, L Lee, S V Parikh, J L Kennedy.   

Abstract

The serotonin (5HT) receptor genes are considered good candidates for Major Depression (MD), Bipolar Disorder (BP), and Obsessive-Compulsive Disorder (OCD). The 5HT1Dbeta receptor gene has at least three polymorphisms known: G861C, T-261G, and the functional T371G (Phe-124-Cys). The aim of this study was to investigate for the presence of linkage disequilibrium between the 5HT1Dbeta receptor gene and BP. Two hundred and ninety probands with DSM-IV BPI, BPII, or Schizoaffective Disorder (Bipolar type) with their living parents were recruited. Genotyping data for the G861C and T371G polymorphisms were analyzed using the Transmission Disequilibrium Test (TDT). One hundred and sixty triads were informative for the TDT on the G861C polymorphism, which showed no preferential transmission of either allele (chi-square = 0.438, df = 1, p =.508). Only four triads were suitable for the analysis on the T371G variant, with the T allele transmitted once and the G allele transmitted four times to the affected. These findings validate further the results of pharmacological studies excluding a direct involvement of the 5HT1Dbeta receptor in the pathogenesis of BP. Further investigations combining genetic and pharmacological strategies are warranted.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11557174     DOI: 10.1016/S0893-133X(01)00259-7

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  5 in total

1.  The rules of variation: amino acid exchange according to the rotating circular genetic code.

Authors:  Fernando Castro-Chavez
Journal:  J Theor Biol       Date:  2010-04-03       Impact factor: 2.691

2.  A functional MRI study of working memory in adolescents and young adults at genetic risk for bipolar disorder: preliminary findings.

Authors:  Heidi W Thermenos; Nikos Makris; Susan Whitfield-Gabrieli; Ariel B Brown; Anthony J Giuliano; Erica H Lee; Stephen V Faraone; Ming T Tsuang; Larry J Seidman
Journal:  Bipolar Disord       Date:  2011-05       Impact factor: 6.744

3.  Pharmacogenetics of citalopram-related side effects in children with depression and/or anxiety disorders.

Authors:  Maya Amitai; Sefi Kronenberg; Miri Carmel; Elena Michaelovsky; Amos Frisch; David Brent; Alan Apter; Alon Chen; Abraham Weizman; Silvana Fennig
Journal:  J Neural Transm (Vienna)       Date:  2016-06-20       Impact factor: 3.575

4.  Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1.

Authors:  Wei Xu; Sarah Cohen-Woods; Qian Chen; Abdul Noor; Jo Knight; Georgina Hosang; Sagar V Parikh; Vincenzo De Luca; Federica Tozzi; Pierandrea Muglia; Julia Forte; Andrew McQuillin; Pingzhao Hu; Hugh M D Gurling; James L Kennedy; Peter McGuffin; Anne Farmer; John Strauss; John B Vincent
Journal:  BMC Med Genet       Date:  2014-01-04       Impact factor: 2.103

5.  Genes Encoding GABA-β and HT1D Receptors in Bipolar I (Manic Phase) Patients.

Authors:  Mohammadreza Moradi; Massoud Saidijam; Reza Yadegarazari; Leila Jahangard; Maryam Seifi; Nasrin Matinnia; Ali Ghaleiha
Journal:  Basic Clin Neurosci       Date:  2018 Mar-Apr
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.